Guangzhou Gloria Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 8

Guangzhou Gloria Biosciences General Information

Description

Developer of differentiated immunotherapies and biologics designed for oncology and life-threatening diseases. The company offers anti-PD-1 monoclonal antibodies, CXCR4 inhibitors, and clinical-stage biological medicines, thereby providing oncology patients and clinical research centers with specialized hardware and biological platforms for targeted cancer treatment and stem cell mobilization.

Contact Information

Website
www.gloriabio.com
Formerly Known As
Guangzhou Yuhang Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 2, Number 1, Nanxiang Third Road
  • Huangpu District
  • Guangzhou, Guangdong 510670
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3rd Floor, Building 2, Number 1, Nanxiang Third Road
  • Huangpu District
  • Guangzhou, Guangdong 510670
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangzhou Gloria Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 28-Nov-2025 Completed Generating Revenue
7. Secondary Transaction - Private 28-Nov-2025 Completed Generating Revenue
6. Secondary Transaction - Private 22-Aug-2023 Completed Generating Revenue
5. Later Stage VC 06-Apr-2022 Completed Generating Revenue
4. Later Stage VC 19-Nov-2021 Completed Generating Revenue
3. Early Stage VC 01-Dec-2020 Completed Generating Revenue
2. Early Stage VC (Series A1) 21-Nov-2018 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2018 Completed Generating Revenue
To view Guangzhou Gloria Biosciences’s complete valuation and funding history, request access »

Guangzhou Gloria Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangzhou Gloria Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
JIC Capital Management Corporate Venture Capital Minority
Yixing JIE investment management Growth/Expansion Minority
6 Dimensions Capital Venture Capital Minority
Frontline BioVentures Venture Capital Minority
Kington Capital Growth/Expansion Minority
You’re viewing 5 of 8 investors. Get the full list »

Guangzhou Gloria Biosciences Investments (1)

Guangzhou Gloria Biosciences’s most recent deal was a PIPE with BioLineRx for . The deal was made on 12-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioLineRx 12-Oct-2023 PIPE Drug Discovery
To view Guangzhou Gloria Biosciences’s complete investments history, request access »

Ready to get started?

Request a free trial

Guangzhou Gloria Biosciences FAQs

  • When was Guangzhou Gloria Biosciences founded?

    Guangzhou Gloria Biosciences was founded in 2016.

  • Where is Guangzhou Gloria Biosciences headquartered?

    Guangzhou Gloria Biosciences is headquartered in Guangzhou, China.

  • What is the size of Guangzhou Gloria Biosciences?

    Guangzhou Gloria Biosciences has 100 total employees.

  • What industry is Guangzhou Gloria Biosciences in?

    Guangzhou Gloria Biosciences’s primary industry is Drug Discovery.

  • Is Guangzhou Gloria Biosciences a private or public company?

    Guangzhou Gloria Biosciences is a Private company.

  • What is Guangzhou Gloria Biosciences’s current revenue?

    The current revenue for Guangzhou Gloria Biosciences is .

  • How much funding has Guangzhou Gloria Biosciences raised over time?

    Guangzhou Gloria Biosciences has raised $45.6M.

  • Who are Guangzhou Gloria Biosciences’s investors?

    JIC Capital Management, Yixing JIE investment management, 6 Dimensions Capital, Frontline BioVentures, and Kington Capital are 5 of 8 investors who have invested in Guangzhou Gloria Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process